June 2 (Reuters) - Mach7 Technologies Ltd (M7T) :
- Expected that at least one of major pending contracts outside U.S. Will likely be signed in FY2018, rather than FY2017 as originally anticipated
- Co now expects to achieve its EBITDA break-even target during FY2018, rather than FY2017
- Company has decided to divest its 3D medical operations
- Targeting to make an announcement with respect to CEO appointment by 30 June 2017.
- "company expects to benefit from costs savings of at least $1.2 million per annum when compared to costs incurred for FY2017"
News: M7T Mach7 Technologies to divest its 3D medical operations
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.005(0.81%) |
Mkt cap ! $150.7M | |||
| Open | High | Low | Value | Volume |
| 62.0¢ | 62.5¢ | 62.0¢ | $23.11K | 37.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9730 | 62.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 3915 | 1 |
View Market Depth
| Last trade - 14.32pm 08/07/2024 (20 minute delay) ? |
| M7T (ASX) Chart |